Adolor Corporation

Morningside Ventures launched Adiso Therapeutics on 10 March with more than $60m invested to date in the Concord, MA-based start-up focusing on the underlying biology of inflammatory diseases without

Mergers and acquisitions propel some of the more dramatic shifts in pharma, an industry characterized by constant change. This article examines the financial performance between 2006 and 2015 of five

Merck & Co. Inc. has put a long-term strategy in play – building a specialty in acute care – with the acquisition of Cubist Pharmaceuticals Inc. Investors, however, may need some more convincing

Merck & Co. Inc. ’s $9.5 billion acquisition of Cubist Pharmaceuticals Inc. will extend the big pharma further into acute care with a portfolio of antibiotics marketed through the hospital settin